Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P15088 (
mast cell
)
14,925
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mechanisms affecting
mast cell
and melanocyte growth and function are still poorly understood. This report summarizes the current state of knowledge on a recently described growth factor for both these cell types and for primitive haematopoietic stem cells.
Stem cell factor
(
SCF
), also named mast cell growth factor or kit-ligand, has only recently been cloned and has been shown to be encoded on human chromosome 12. It may be of specific importance in cutaneous physiology and pathology since it is produced by several cell types in the skin (e.g. fibroblasts, keratinocytes, endothelial cells) and since it affects melanocyte and
mast cell
growth, survival, secretion and adhesion as well as migration into tissues. Defects in the genes encoding for the
SCF
receptor (c-kit-protein) have been shown to be responsible for human piebaldism. A pathogenetic role in mastocytosis has recently been proposed, but remains to be proven.
SCF
receptor expression is decreased on cells of some malignant cell lines compared to their physiological counterparts, making it unlikely that
SCF
is a key factor in malignant transformation and cellular hyperproliferation. In haematopoiesis,
SCF
acts primarily in concert with other growth factors, and we show here that alone in serum-free culture it has no effect on
mast cell
growth. Furthermore, there is evidence that besides
SCF
, additional
mast cell
growth factors are secreted by fibroblasts and keratinocytes, suggesting a complex orchestration of several growth factors in the regulation of cutaneous growth and differentiation in which
SCF
plays only one part.
...
PMID:Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. 753 33
We investigated the increase in
mast cell
numbers at the sites of inoculation of keratinocyte-derived squamous cell carcinoma cell line (KCMH-1) cells in mice. A significant increase in the number of mast cells was observed at the sites of tumours developed at the sites of inoculation of the KCMH-1 cells. Enhancement of
mast cell
growth was observed by culturing bone marrow-derived mast cells (BMMC) on NIH/3T3 fibroblast monolayers in the presence of conditioned medium (TCM) obtained from KCMH-1. Activities of known factors for
mast cell
growth, such as interleukin-3 (IL-3), IL-4, IL-9, IL-10 and
stem cell factor
(
SCF
), were not detected in the TCM. Nerve growth factor (NGF) did not induce
mast cell
growth. Mast cell growth induced by the TCM needed 3T3 fibroblasts. These results suggest that KCMH-1 cells may produce a factor which induces
mast cell
growth with 3T3 fibroblasts, other than the already known
mast cell
growth factors. This may be the mechanism of
mast cell
accumulation at sites of tumours.
...
PMID:Enhancement of fibroblast-dependent mast cell growth in mice by a conditioned medium of keratinocyte-derived squamous cell carcinoma cells. 753 34
The effect of FLT3/FLK2 ligand (FL) on the growth of primitive hematopoietic cells was investigated using ThyloSca1+ stem cells. FL was observed to interact with a variety of factors to initiate colony formation by stem cells. When stem cells were stimulated in liquid culture with FL plus interleukin (IL)-3, IL-6, granulocyte colony-stimulating factor (G-CSF), or
stem cell factor
(
SCF
), cells capable of forming colonies in secondary methylcellulose cultures (CFU-c) were produced in high numbers. However, only FL plus IL-6 supported an increase in the number of cells capable of forming colonies in the spleens of irradiated mice (CFU-s). Experiments with accessory cell-depleted bone marrow (Lin- BM) showed that FL alone lacks significant colony-stimulating activity for progenitor cells. Nevertheless, FL enhanced the growth of granulocyte-macrophage progenitors (CFU-GM) in cultures containing
SCF
, G-CSF, IL-6, or IL-11. In these assays, FL increased the number of CFU-GM initiating colony formation (recruitment), as well as the number of cells per colony (synergy). Many of the colonies were macroscopic and contained greater than 2 x 10(4) granulocytes and macrophages. Therefore, FL appears to function as a potent costimulus for primitive cells of high proliferative potential (HPP). FL was also observed to costimulate the expansion of CFU-GM in liquid cultures of Lin- BM. In contrast, FL had no growth-promoting affects on progenitors committed to the erythrocyte, megakaryocyte, eosinophil, or
mast cell
lineages.
...
PMID:FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units. 753 80
The regulation of tissue
mast cell
number depends both on the rate of production of
mast cell
precursors and the length of survival of mature mast cells within tissues. Once
mast cell
precursors target to tissues, their survival may largely be dependent upon the local production of
stem cell factor
(
SCF
). Withdrawal of interleukin (IL)-3 results in
mast cell
apoptosis. The apoptotic changes following IL-3 deprivation are prevented by the addition of
SCF
which exerts its rescue effect upon interaction with its c-Kit tyrosine kinase receptor. Mast cells undergo apoptosis on withdrawal of IL-3 coincident with a decrease in endogenous bcl-2 mRNA; however,
SCF
does not induce expression of bcl-2 when added to these cells. When overexpressed, bcl-2 prolongs survival of bcl-2-transfected mast cells following IL-3 deprivation. Transforming growth factor-beta was found to specifically prevent this
SCF
-mediated rescue from apoptosis, probably by down-regulating the expression of c-Kit. Thus, microenvironmental factors play an important role in regulating
mast cell
numbers by effecting survival in the periphery.
...
PMID:The role of c-Kit and its ligand, stem cell factor, in mast cell apoptosis. 754 59
We have investigated the capacity of interleukin (IL)-4 or
stem cell factor
(
SCF
) to induce direct mediator release from rodent peritoneal mast cells, and also to induce or regulate cytokine gene expression in the human HMC-1
mast cell
line.
SCF
, but not IL-4, induced low levels of serotonin release from mouse or rat peritoneal mast cells; rat mast cells acquired enhanced responsiveness to
SCF
during culture. IL-4, but not
SCF
, enhanced ionomycin-induced transcription and secretion of several genes, including the cytokines IL-3, IL-4, granulocyte/macrophage-colony-stimulating factor, IL-8 and the receptor for IL-6 in the human HMC-1
mast cell
line.
...
PMID:Effects of interleukin-4 or stem cell factor on mast cell mediator release and cytokine gene expression. 754 63
Besides
stem cell factor
(
SCF
), additional fibroblast-derived
mast cell
growth factors have previously been described. Since keratinocytes have also been shown to produce
SCF
, we have studied the ability of culture supernatants from the human HaCaT keratinocyte cell line to induce
SCF
-independent
mast cell
differentiation. The immature human mast cells of the HMC-1 line which express a mutant continuously activated
SCF
receptor were used as model target cells. Culture supernatants from differentiating keratinocytes (at day 11 of culture), and far less so those from proliferating keratinocytes (day 4 of culture), caused a marked, dose-dependent increase of histamine and tryptase in HMC-1 cells. This suggests that human HaCaT keratinocytes release
mast cell
differentiation factors other than
SCF
, to a degree related to their state of differentiation.
...
PMID:Human keratinocytes release mast cell differentiation factors other than stem cell factor. 754 60
It is possible to divide surface receptors on mast cells conceptually into three groups. The first consists of immune response receptors. The index receptor for this group is Fc epsilon RI, now joined by Fc gamma receptors and receptors for complement products. The second group of receptors are those that are involved in growth and differentiation, such as those for interleukin-3 and
stem cell factor
. The third group consists of receptors regulating
mast cell
trafficking and distribution. Principle among the latter group of receptors are those that engage extracellular matrix components, including the classical integrin receptors. The engagement of mast cells to matrix components not only has relevance in determining the tissue distribution of mast cells, but also appears to have a major influence on the biologic responsiveness of mast cells to immune- and growth-factor-receptor-mediated signals.
...
PMID:Interaction of mast cells with extracellular matrix proteins. 754 3
Stem cell factor
(
SCF
), the ligand for the receptor (SCFR) that is encoded by the c-kit proto-oncogene, has many important effects in mouse and human
mast cell
development, survival, and function.
SCF
can promote
mast cell
survival by suppressing apoptosis, induce mast cell hyperplasia in murine rodents, experimental primates and humans, directly induce SCFR-dependent
mast cell
mediator release, and significantly modulate the extent of
mast cell
activation by Fc epsilon RI-dependent mechanisms. These findings raise several clinical issues and, in some cases, point to potentially significant therapeutic opportunities.
...
PMID:Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor. 754 1
By using the reverse transcriptase (RT)-PCR and in situ hybridization we have studied the expression of mRNA for IL-5 and IL-4 in human lung mast cells induced by cross-linkage of high affinity Fc epsilon Rs. Lung mast cells were purified using affinity magnetic selection with mAb YB5.B8 against c-kit to achieve a final
mast cell
purity > 93%. Purified mast cells were precultured with
stem cell factor
(
SCF
) (10 ng/ml) and myeloma IgE (3 micrograms/ml) for 16 h before challenge with anti-IgE (1 or 10 micrograms/ml). IgE-dependent activation of lung mast cells caused expression of IL-5 mRNA, which was evident by 2 h and persisted for up to 48-72 h in all of 12 experiments, whereas IL-4 mRNA expression was of a shorter duration and was demonstrable in 6 of 13 experiments. We confirmed that mast cells, and not T cells, were the source of these cytokine messages by using reverse transcriptase-PCR in cell preparations containing known numbers of mast cells and T cells, in situ hybridization in enriched
mast cell
preparations, and double in situ hybridization-immunocytochemical staining. IL-5 mRNA expression did not require the pretreatment of cells with
SCF
, whereas expression of IL-4 mRNA seemed to require both anti-IgE and
SCF
. The strength of IL-5 mRNA signal was related to anti-IgE concentration. Immunoreactive IL-5 was detectable 8 h after anti-IgE challenge, and 10(6) mast cells generated a mean of 731 +/- 400 pg of IL-5 into the supernatant during 48-h culture, but no IL-4 product was detectable. These findings demonstrate the capacity of human lung mast cells to transcribe IL-4 and IL-5 after IgE-dependent activation and to synthesize and release immunoreactive IL-5.
...
PMID:IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells. 754 33
We assessed the effects of the c-kit ligand,
stem cell factor
(
SCF
), in the jejunal mucosal mast cell hyperplasia that occurs during infection with the intestinal nematodes, Nippostrongylus brasiliensis or Trichinella spiralis in rats. Compared with vehicle-treated rats, rats treated with
SCF
(25 micrograms/kg/d, intravenous [i.v.] for 14 days) during N brasiliensis infection exhibited significantly higher levels of the rat mucosal
mast cell
(MMC)-associated protease, rat mast cell protease II (RMCP II) in the jejunum and serum on day 8 of infection, but not on days 10 or 15 of infection. By contrast, in comparison to rats treated with normal sheep IgG, rats treated with a polyclonal sheep antirat
SCF
antibody exhibited markedly decreased numbers of jejunal MMCs, levels of jejunal RMCP II, and serum concentrations of RMCP II during infection with either nematode, particularly at the earlier intervals of infection (< or = day 10). Taken together, these findings indicate that
SCF
importantly contributes to MMC hyperplasia and/or survival during N brasiliensis or T spiralis infection in rats, but that levels of endogenous
SCF
are adequate to sustain near maximal MMC hyperplasia during infection with these nematodes. Notably, treatment of rats with
SCF
somewhat increased, and treatment with anti-
SCF
significantly decreased, parasite egg production during N brasiliensis infection. This finding raises the interesting possibility that certain activities of intestinal MMCs may contribute to parasite fecundity during infection with this nematode.
...
PMID:Stem cell factor contributes to intestinal mucosal mast cell hyperplasia in rats infected with Nippostrongylus brasiliensis or Trichinella spiralis, but anti-stem cell factor treatment decreases parasite egg production during N brasiliensis infection. 754 50
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>